Beyond Glycemic Control: New Study Shows Sea Buckthorn Peptides Offer Superior Kidney Protection

While first-line therapies like metformin are effective for glycemic control, they offer limited ability to repair existing kidney damage. This creates a clear market need for innovative, food-derived ingredients that can offer a dual-action approach: managing blood sugar while actively protecting and repairing the kidneys.

As a leader in small-molecule peptide technology, we are proud to spotlight groundbreaking new research on our Sea Buckthorn Protein Peptide (SSPE).

Derived from nutrient-rich sea buckthorn (Hippophae rhamnoides L.) meal, this is not a simple extract. Our proprietary process uses controlled enzymatic hydrolysis and advanced purification to create a high-bioavailability, small-molecule peptide packed with functional benefits.

A recent animal study revealed the powerful, multi-faceted effects of SSPE. Here are the key findings:

1. Powerful Glycemic Control (On Par with Metformin)

After 8 weeks, the SSPE groups showed a dramatic reduction in blood glucose, bringing it down to levels statistically identical to the positive control (metformin) group. This confirms SSPE is a highly effective agent for blood sugar management.

2. Superior Kidney Protection (Outperforming Metformin)

This is the most significant finding. When researchers measured key markers of kidney damage—such as serum creatinine, serum uric acid, and 24-hour urine protein—the SSPE groups were not just significantly lower than the diabetic control group, but they were also significantly lower (P<0.05) than the metformin group.

This demonstrates that SSPE has a superior protective effect on kidney function, going beyond the capabilities of the standard pharmaceutical.

3. Reversal of Kidney Structural Damage

Pathology reports confirmed what the blood markers showed. The diabetic control group exhibited severe structural damage to the kidneys (e.g., glomerular hypertrophy, basement membrane thickening).

In contrast, the SSPE groups showed a significant reversal of these lesions, with kidney morphology returning to a near-normal state. This confirms SSPE can help reverse early structural damage caused by DN.

What This Means for Your B2B Brand

For companies in the Dietary supplement, Functional Food, and medical nutrition spaces, this research is critical.

It positions Sea Buckthorn Protein Peptide as a premier, science-backed ingredient for the next generation of metabolic health products. It moves "beyond" simple blood sugar support and offers a profound, marketable benefit for kidney health—a primary concern for consumers in this category.

As a cGMP-certified B2B manufacturer, we have successfully scaled this technology. Our SSPE is a stable, spray-dried, and highly soluble ingredient ready for your formulation.

Are you developing a product for blood sugar, metabolic health, or kidney support?

Contact our team today to request a full Technical Data Sheet (TDS), the complete study details, or a development sample.